BACKGROUND: The open-artery hypothesis postulates that late opening of an infarct-related artery after myocardial infarction will improve clinical outcomes. We evaluated the quality-of-life and economic outcomes associated with the use of this strategy. METHODS: We compared percutaneous coronary intervention (PCI) plus stenting with medical therapy alone in high-risk patients in stable condition who had a totally occluded infarct-related artery 3 to 28 days after myocardial infarction. In 951 patients (44% of those eligible), we assessed quality of life by means of a battery of tests that included two principal outcome measures, the Duke Activity Status Index (DASI) (which measures cardiac physical function on a scale from 0 to 58, with higher scores indicating better function) and the Medical Outcomes Study 36-Item Short-Form Mental Health Inventory 5 (which measures psychological well-being). Structured quality-of-life interviews were performed at baseline and at 4, 12, and 24 months. Costs of treatment were assessed for 458 of 469 patients in the United States (98%), and 2-year cost-effectiveness was estimated. RESULTS: At 4 months, the medical-therapy group, as compared with the PCI group, had a clinically marginal decrease of 3.4 points in the DASI score (P=0.007). At 1 and 2 years, the differences were smaller. No significant differences in psychological well-being were observed. For the 469 patients in the United States, cumulative 2-year costs were approximately $7,000 higher in the PCI group (P<0.001), and the quality-adjusted survival was marginally longer in the medical-therapy group. CONCLUSIONS: PCI was associated with a marginal advantage in cardiac physical function at 4 months but not thereafter. At 2 years, medical therapy remained significantly less expensive than routine PCI and was associated with marginally longer quality-adjusted survival. (ClinicalTrials.gov number, NCT00004562.) 2009 Massachusetts Medical Society
RCT Entities:
BACKGROUND: The open-artery hypothesis postulates that late opening of an infarct-related artery after myocardial infarction will improve clinical outcomes. We evaluated the quality-of-life and economic outcomes associated with the use of this strategy. METHODS: We compared percutaneous coronary intervention (PCI) plus stenting with medical therapy alone in high-risk patients in stable condition who had a totally occluded infarct-related artery 3 to 28 days after myocardial infarction. In 951 patients (44% of those eligible), we assessed quality of life by means of a battery of tests that included two principal outcome measures, the Duke Activity Status Index (DASI) (which measures cardiac physical function on a scale from 0 to 58, with higher scores indicating better function) and the Medical Outcomes Study 36-Item Short-Form Mental Health Inventory 5 (which measures psychological well-being). Structured quality-of-life interviews were performed at baseline and at 4, 12, and 24 months. Costs of treatment were assessed for 458 of 469 patients in the United States (98%), and 2-year cost-effectiveness was estimated. RESULTS: At 4 months, the medical-therapy group, as compared with the PCI group, had a clinically marginal decrease of 3.4 points in the DASI score (P=0.007). At 1 and 2 years, the differences were smaller. No significant differences in psychological well-being were observed. For the 469 patients in the United States, cumulative 2-year costs were approximately $7,000 higher in the PCI group (P<0.001), and the quality-adjusted survival was marginally longer in the medical-therapy group. CONCLUSIONS: PCI was associated with a marginal advantage in cardiac physical function at 4 months but not thereafter. At 2 years, medical therapy remained significantly less expensive than routine PCI and was associated with marginally longer quality-adjusted survival. (ClinicalTrials.gov number, NCT00004562.) 2009 Massachusetts Medical Society
Authors: D B Mark; R A Harrington; A M Lincoff; R M Califf; C L Nelson; A A Tsiatis; H Buell; K W Mahaffey; L Davidson-Ray; E J Topol Journal: Circulation Date: 2000-02-01 Impact factor: 29.690
Authors: Daniel B Mark; Charlotte L Nelson; Kevin J Anstrom; Sana M Al-Khatib; Anastasios A Tsiatis; Patricia A Cowper; Nancy E Clapp-Channing; Linda Davidson-Ray; Jeanne E Poole; George Johnson; Jill Anderson; Kerry L Lee; Gust H Bardy Journal: Circulation Date: 2006-07-03 Impact factor: 29.690
Authors: Judith S Hochman; Gervasio A Lamas; Genell L Knatterud; Christopher E Buller; Vladimir Dzavik; Daniel B Mark; Harmony R Reynolds; Harvey D White Journal: Am Heart J Date: 2005-10 Impact factor: 4.749
Authors: M A Hlatky; R E Boineau; M B Higginbotham; K L Lee; D B Mark; R M Califf; F R Cobb; D B Pryor Journal: Am J Cardiol Date: 1989-09-15 Impact factor: 2.778
Authors: M A Hlatky; W J Rogers; I Johnstone; D Boothroyd; M M Brooks; B Pitt; G Reeder; T Ryan; H Smith; P Whitlow; R Wiens; D B Mark Journal: N Engl J Med Date: 1997-01-09 Impact factor: 91.245
Authors: Daniel B Mark; Kevin J Anstrom; Jie L Sun; Nancy E Clapp-Channing; Anastasios A Tsiatis; Linda Davidson-Ray; Kerry L Lee; Gust H Bardy Journal: N Engl J Med Date: 2008-09-04 Impact factor: 91.245
Authors: Daniel B Mark; Kevin J Anstrom; Steven E McNulty; Greg C Flaker; Andrew M Tonkin; Warren M Smith; William D Toff; Paul Dorian; Nancy E Clapp-Channing; Jill Anderson; George Johnson; Eleanor B Schron; Jeanne E Poole; Kerry L Lee; Gust H Bardy Journal: Am Heart J Date: 2010-04 Impact factor: 4.749
Authors: Gerard Devlin; Harmony R Reynolds; Daniel B Mark; James M Rankin; Antonio C Carvalho; Carlos Vozzi; George Sopko; Paulo Caramori; Vladimir Džavík; Michael Ragosta; Sandra A Forman; Gervasio A Lamas; Judith S Hochman Journal: Am Heart J Date: 2011-01 Impact factor: 4.749
Authors: Maria Mori Brooks; Sheng-Chia Chung; Tarek Helmy; William B Hillegass; Jorge Escobedo; Kathryn A Melsop; Elaine M Massaro; Robert D McBane; Pamela Hyde; Mark A Hlatky Journal: Circulation Date: 2010-10-11 Impact factor: 29.690
Authors: Judith S Hochman; Harmony R Reynolds; Vladimír Dzavík; Christopher E Buller; Witold Ruzyllo; Zygmunt P Sadowski; Aldo P Maggioni; Antonio C Carvalho; James M Rankin; Harvey D White; Suzanne Goldberg; Sandra A Forman; Daniel B Mark; Gervasio A Lamas Journal: Circulation Date: 2011-10-24 Impact factor: 29.690
Authors: Gervasio A Lamas; Kevin J Anstrom; Ana Navas-Acien; Robin Boineau; Hwasoon Kim; Yves Rosenberg; Mario Stylianou; Teresa L Z Jones; Bonnie R Joubert; Regina M Santella; Esteban Escolar; Y Wady Aude; Vivian Fonseca; Thomas Elliott; Eldrin F Lewis; Michael E Farkouh; David M Nathan; Ana C Mon; Leigh Gosnell; Jonathan D Newman; Daniel B Mark Journal: Am Heart J Date: 2022-05-19 Impact factor: 5.099
Authors: Daniel B Mark; J David Knight; Eric J Velazquez; Jonathan G Howlett; John A Spertus; Ljubomir T Djokovic; Tina M Harding; Gena R Rankin; Laura A Drew; Bozena Szygula-Jurkiewicz; Christopher Adlbrecht; Kevin J Anstrom Journal: Am Heart J Date: 2009-04-01 Impact factor: 4.749
Authors: Christopher Adlbrecht; Kurt Huber; Harmony R Reynolds; Antonio C Carvalho; Vladimír Džavík; Philippe Gabriel Steg; Li Liu; Paolo Marino; Camille A Pearte; James M Rankin; Harvey D White; Gervasio A Lamas; Judith S Hochman Journal: Int J Cardiol Date: 2014-03-28 Impact factor: 4.164